221 related articles for article (PubMed ID: 30059194)
1. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
[TBL] [Abstract][Full Text] [Related]
4. Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.
Fujita Y; Kinoshita M; Furukawa Y; Nagano T; Hashimoto H; Hirami Y; Kurimoto Y; Arakawa K; Yamazaki K; Okada Y; Katakami N; Uno E; Matsubara Y; Fukushima M; Nada A; Losordo DW; Asahara T; Okita Y; Kawamoto A
Circ J; 2014; 78(2):490-501. PubMed ID: 24257136
[TBL] [Abstract][Full Text] [Related]
5. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC
Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483
[TBL] [Abstract][Full Text] [Related]
6. Circulatory Rejuvenated EPCs Derived from PAOD Patients Treated by CD34
Chen YC; Sheu JJ; Chiang JY; Shao PL; Wu SC; Sung PH; Li YC; Chen YL; Huang TH; Chen KH; Yip HK
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114267
[TBL] [Abstract][Full Text] [Related]
7. Outcome From a Randomized Controlled Clinical Trial - Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT).
Horie T; Yamazaki S; Hanada S; Kobayashi S; Tsukamoto T; Haruna T; Sakaguchi K; Sakai K; Obara H; Morishita K; Saigo K; Shintani Y; Kubo K; Hoshino J; Oda T; Kaneko E; Nishikido M; Ioji T; Kaneda H; Fukushima M;
Circ J; 2018 Jul; 82(8):2165-2174. PubMed ID: 29877199
[TBL] [Abstract][Full Text] [Related]
8. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia.
Wang X; Jiang L; Wang X; Yin F; Li G; Feng X; Wang K; Sun S
Ann Vasc Surg; 2014 Aug; 28(6):1501-12. PubMed ID: 24632316
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.
Dong Z; Chen B; Fu W; Wang Y; Guo D; Wei Z; Xu X; Mendelsohn FO
J Vasc Surg; 2013 Aug; 58(2):404-411.e3. PubMed ID: 23611711
[TBL] [Abstract][Full Text] [Related]
10. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia - The SCELTA Trial.
Liotta F; Annunziato F; Castellani S; Boddi M; Alterini B; Castellini G; Mazzanti B; Cosmi L; Acquafresca M; Bartalesi F; Dilaghi B; Dorigo W; Graziani G; Bartolozzi B; Bellandi G; Carli G; Bartoloni A; Fargion A; Fassio F; Fontanari P; Landini G; Lucente EAM; Michelagnoli S; Orsi Battaglini C; Panigada G; Pigozzi C; Querci V; Santarlasci V; Parronchi P; Troisi N; Baggiore C; Romagnani P; Mannucci E; Saccardi R; Pratesi C; Gensini G; Romagnani S; Maggi E
Circ J; 2018 May; 82(6):1688-1698. PubMed ID: 29576595
[TBL] [Abstract][Full Text] [Related]
13. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia.
Ozturk A; Kucukardali Y; Tangi F; Erikci A; Uzun G; Bashekim C; Sen H; Terekeci H; Narin Y; Ozyurt M; Ozkan S; Sayan O; Rodop O; Nalbant S; Sıldıroglu O; Yalnız FF; Senkal IV; Sabuncu H; Oktenli C
J Diabetes Complications; 2012; 26(1):29-33. PubMed ID: 22240264
[TBL] [Abstract][Full Text] [Related]
14. Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia.
Sun L; Wu L; Qiao Z; Yu J; Li L; Li S; Liu Q; Hu Y; Xu N; Huang P
Cytotherapy; 2014 Aug; 16(8):1110-6. PubMed ID: 24834816
[TBL] [Abstract][Full Text] [Related]
15. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs.
Kawamura A; Horie T; Tsuda I; Abe Y; Yamada M; Egawa H; Iida J; Sakata H; Onodera K; Tamaki T; Furui H; Kukita K; Meguro J; Yonekawa M; Tanaka S
J Artif Organs; 2006; 9(4):226-33. PubMed ID: 17171401
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.
Murphy MP; Lawson JH; Rapp BM; Dalsing MC; Klein J; Wilson MG; Hutchins GD; March KL
J Vasc Surg; 2011 Jun; 53(6):1565-74.e1. PubMed ID: 21514773
[TBL] [Abstract][Full Text] [Related]
18. Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant.
Jonsson TB; Larzon T; Arfvidsson B; Tidefelt U; Axelsson CG; Jurstrand M; Norgren L
Int Angiol; 2012 Feb; 31(1):77-84. PubMed ID: 22330628
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia.
Losordo DW; Kibbe MR; Mendelsohn F; Marston W; Driver VR; Sharafuddin M; Teodorescu V; Wiechmann BN; Thompson C; Kraiss L; Carman T; Dohad S; Huang P; Junge CE; Story K; Weistroffer T; Thorne TM; Millay M; Runyon JP; Schainfeld R;
Circ Cardiovasc Interv; 2012 Dec; 5(6):821-30. PubMed ID: 23192920
[TBL] [Abstract][Full Text] [Related]
20. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.
Tournois C; Pignon B; Sevestre MA; Al-Rifai R; Creuza V; Poitevin G; François C; Nguyen P
Cytotherapy; 2017 Feb; 19(2):299-310. PubMed ID: 27914820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
